GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Beneish M-Score

Sartorius AG (XTER:SRT) Beneish M-Score : -2.69 (As of Apr. 26, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.69 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Sartorius AG's Beneish M-Score or its related term are showing as below:

XTER:SRT' s Beneish M-Score Range Over the Past 10 Years
Min: -2.96   Med: -2.59   Max: -2.13
Current: -2.69

During the past 13 years, the highest Beneish M-Score of Sartorius AG was -2.13. The lowest was -2.96. And the median was -2.59.


Sartorius AG Beneish M-Score Historical Data

The historical data trend for Sartorius AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Beneish M-Score Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.83 -2.69 -2.60 -2.32 -2.96

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.66 -2.91 -2.93 -2.96 -2.69

Competitive Comparison of Sartorius AG's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Sartorius AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Beneish M-Score falls into.



Sartorius AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sartorius AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1103+0.528 * 1.1458+0.404 * 1.1797+0.892 * 0.8172+0.115 * 0.9796
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2267+4.679 * -0.051553-0.327 * 1.0468
=-2.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was €402 Mil.
Revenue was 819.6 + 849.8 + 810.7 + 832 = €3,312 Mil.
Gross Profit was 396.1 + 331.1 + 359.8 + 406.9 = €1,494 Mil.
Total Current Assets was €2,779 Mil.
Total Assets was €10,628 Mil.
Property, Plant and Equipment(Net PPE) was €2,131 Mil.
Depreciation, Depletion and Amortization(DDA) was €364 Mil.
Selling, General, & Admin. Expense(SGA) was €862 Mil.
Total Current Liabilities was €1,373 Mil.
Long-Term Debt & Capital Lease Obligation was €4,863 Mil.
Net Income was 36.7 + 8.4 + 8.6 + 95 = €149 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = €0 Mil.
Cash Flow from Operations was 45.4 + 311 + 180 + 160.2 = €697 Mil.
Total Receivables was €444 Mil.
Revenue was 903.2 + 1061.8 + 1052.6 + 1035.6 = €4,053 Mil.
Gross Profit was 454.8 + 550 + 556.2 + 533.7 = €2,095 Mil.
Total Current Assets was €2,008 Mil.
Total Assets was €6,965 Mil.
Property, Plant and Equipment(Net PPE) was €1,781 Mil.
Depreciation, Depletion and Amortization(DDA) was €297 Mil.
Selling, General, & Admin. Expense(SGA) was €860 Mil.
Total Current Liabilities was €1,658 Mil.
Long-Term Debt & Capital Lease Obligation was €2,246 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(402.4 / 3312.1) / (443.5 / 4053.2)
=0.121494 / 0.10942
=1.1103

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2094.7 / 4053.2) / (1493.9 / 3312.1)
=0.516802 / 0.451043
=1.1458

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2779.1 + 2130.8) / 10627.8) / (1 - (2007.6 + 1780.8) / 6964.7)
=0.538014 / 0.456057
=1.1797

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3312.1 / 4053.2
=0.8172

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(296.8 / (296.8 + 1780.8)) / (363.8 / (363.8 + 2130.8))
=0.142857 / 0.145835
=0.9796

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(861.9 / 3312.1) / (859.8 / 4053.2)
=0.260228 / 0.212129
=1.2267

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4863 + 1372.8) / 10627.8) / ((2246.2 + 1657.7) / 6964.7)
=0.586744 / 0.560527
=1.0468

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(148.7 - 0 - 696.6) / 10627.8
=-0.051553

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sartorius AG has a M-score of -2.69 suggests that the company is unlikely to be a manipulator.


Sartorius AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.